DE3787121T2 - Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. - Google Patents
Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen.Info
- Publication number
- DE3787121T2 DE3787121T2 DE87304827T DE3787121T DE3787121T2 DE 3787121 T2 DE3787121 T2 DE 3787121T2 DE 87304827 T DE87304827 T DE 87304827T DE 3787121 T DE3787121 T DE 3787121T DE 3787121 T2 DE3787121 T2 DE 3787121T2
- Authority
- DE
- Germany
- Prior art keywords
- production
- leukemia virus
- feline leukemia
- virus antigens
- cat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000714165 Feline leukemia virus Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 241000282326 Felis catus Species 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86858586A | 1986-05-30 | 1986-05-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3787121D1 DE3787121D1 (de) | 1993-09-30 |
| DE3787121T2 true DE3787121T2 (de) | 1994-04-07 |
Family
ID=25351957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE87304827T Expired - Lifetime DE3787121T2 (de) | 1986-05-30 | 1987-06-01 | Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0247904B1 (de) |
| JP (1) | JP2656521B2 (de) |
| AT (1) | ATE93394T1 (de) |
| AU (1) | AU607427B2 (de) |
| DE (1) | DE3787121T2 (de) |
| DK (1) | DK46988A (de) |
| ES (1) | ES2058113T3 (de) |
| IL (1) | IL82720A0 (de) |
| NZ (1) | NZ220500A (de) |
| PT (1) | PT84976B (de) |
| WO (1) | WO1987007301A1 (de) |
| ZA (1) | ZA873922B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5152982A (en) * | 1984-03-26 | 1992-10-06 | Chiron Corporation | Compositions and methods for FeLV vaccination |
| ES2179854T3 (es) * | 1988-12-13 | 2003-02-01 | Harvard College | Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas. |
| WO1993009238A1 (en) * | 1991-11-08 | 1993-05-13 | The Upjohn Company | Feline leukemia virus vaccines |
| GB9210337D0 (en) * | 1992-05-14 | 1992-07-01 | Univ Court Of The University O | Feline leukaemia virus vaccine |
| US6013506A (en) * | 1995-06-05 | 2000-01-11 | Wardley; Richard C. | Feline leukemia virus vaccines |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| EP1757304A1 (de) | 2005-08-26 | 2007-02-28 | Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut | Pharmazeutische Zusammensetzung, und ihr Verwendung zur prophylaktische und therapeutische Behandlung von retroviralen Krankenheiten |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4406885A (en) * | 1978-12-28 | 1983-09-27 | Research Corporation | Preparation of native oncornavirus envelope subunits and vaccines therefrom |
| US4264587A (en) * | 1979-08-01 | 1981-04-28 | Pedersen Niels C | Vaccine for preventing persistent feline leukemia viremia in cats |
| US4434158A (en) * | 1981-02-11 | 1984-02-28 | Cornell Research Foundation | Cysteine delivery system |
| US4701416A (en) * | 1983-12-09 | 1987-10-20 | Cetus Corporation | Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV |
| EP0156299A3 (de) * | 1984-03-26 | 1987-04-01 | Chiron Corporation | LTR-modifizierte virale Vakzine |
| EP0173997A1 (de) * | 1984-09-06 | 1986-03-12 | Chiron Corporation | Katzenleukämievirusproteinimpfstoffe und ihre Herstellung |
| WO1986003224A1 (en) * | 1984-11-29 | 1986-06-05 | Scripps Clinic And Research Foundation | Polypeptides and antibodies related to deglycosylated viral glycoproteins |
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
-
1987
- 1987-05-29 WO PCT/US1987/001278 patent/WO1987007301A1/en unknown
- 1987-05-29 AU AU75479/87A patent/AU607427B2/en not_active Expired
- 1987-05-29 PT PT84976A patent/PT84976B/pt not_active IP Right Cessation
- 1987-05-29 NZ NZ220500A patent/NZ220500A/xx unknown
- 1987-05-29 IL IL82720A patent/IL82720A0/xx unknown
- 1987-05-29 JP JP62503637A patent/JP2656521B2/ja not_active Expired - Lifetime
- 1987-06-01 EP EP87304827A patent/EP0247904B1/de not_active Expired - Lifetime
- 1987-06-01 DE DE87304827T patent/DE3787121T2/de not_active Expired - Lifetime
- 1987-06-01 AT AT87304827T patent/ATE93394T1/de active
- 1987-06-01 ES ES87304827T patent/ES2058113T3/es not_active Expired - Lifetime
- 1987-06-02 ZA ZA873922A patent/ZA873922B/xx unknown
-
1988
- 1988-01-29 DK DK046988A patent/DK46988A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2058113T3 (es) | 1994-11-01 |
| DK46988D0 (da) | 1988-01-29 |
| DE3787121D1 (de) | 1993-09-30 |
| PT84976A (pt) | 1987-06-01 |
| JP2656521B2 (ja) | 1997-09-24 |
| ZA873922B (en) | 1988-02-24 |
| DK46988A (da) | 1988-01-29 |
| EP0247904B1 (de) | 1993-08-25 |
| ATE93394T1 (de) | 1993-09-15 |
| AU607427B2 (en) | 1991-03-07 |
| PT84976B (pt) | 1990-02-08 |
| EP0247904A1 (de) | 1987-12-02 |
| JPH01503273A (ja) | 1989-11-09 |
| AU7547987A (en) | 1987-12-22 |
| WO1987007301A1 (en) | 1987-12-03 |
| IL82720A0 (en) | 1987-11-30 |
| NZ220500A (en) | 1991-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE249840T1 (de) | Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung | |
| ATE61228T1 (de) | Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff. | |
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| DE3575520D1 (de) | Rabies-vakzine und verfahren zur herstellung. | |
| DE3773963D1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
| ATE259878T1 (de) | Verfahren zur verbesserung der immunogenität einer immunogenen zusammensetzung oder eines haptens und verwendung zur herstellung von impfstoffen | |
| ES2050114T3 (es) | Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia. | |
| DE3784151T2 (de) | Verfahren zur herstellung von alkylhalosilanen. | |
| DE68915915T2 (de) | Verfahren zur Herstellung von cyclischen Polysiloxanen. | |
| DK163062C (da) | Antigen, immunogen, proteinholdig vaccine imod coccidiose | |
| DE3786832D1 (de) | Verfahren zur herstellung von immunoglobulinzubereitungen fuer intravenoese injektion. | |
| AT364718B (de) | Verfahren zur herstellung neuer muramylpeptid antigen-konjugate | |
| DE3787121T2 (de) | Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen. | |
| DE3868176D1 (de) | Verfahren zur herstellung von siliciumtetrachlorid. | |
| DE3585578D1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| EP0193585A4 (de) | Kreuzreaktive und schützende epitope von circumsporozoit-proteinen. | |
| DE3787706T2 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
| DE3777577D1 (de) | Verfahren zur herstellung von siliziumcarbid-whiskern. | |
| DE3750642D1 (de) | Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene. | |
| DE3766046D1 (de) | Verfahren zur herstellung von isopropylakohol und tertiaeren c4-bis c5-alkoholen. | |
| DE3671603D1 (de) | Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose. | |
| ATE45500T1 (de) | Verfahren zur herstellung von tuberkulin-l antigen. | |
| DD138329A1 (de) | Verfahren zur herstellung von tetanus-impfstoffen | |
| DE3685735D1 (de) | Verfahren zur herstellung von siliziumnitridpulver. | |
| ATE112855T1 (de) | Verfahren und zusammensetzungen betreffend regressions-assoziierte antigene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |